 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1fm5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of human cd69
|
|
Structure:
|
 |
Early activation antigen cd69. Chain: a. Fragment: c-type lectin-like domain. Synonym: early t-cell activation antigen p6, gp32/28, leu- 23, mlr-3, ea1, bl-ac/p26, activation inducer molecule, aim. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.27Å
|
R-factor:
|
0.243
|
R-free:
|
0.299
|
|
|
Authors:
|
 |
K.Natarajan,M.W.Sawicki,D.H.Margulies,R.A.Mariuzza
|
Key ref:
|
 |
K.Natarajan
et al.
(2000).
Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells.
Biochemistry,
39,
14779-14786.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Aug-00
|
Release date:
|
18-Dec-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q07108
(CD69_HUMAN) -
Early activation antigen CD69
|
|
|
|
Seq: Struc:
|
 |
 |
 |
199 a.a.
118 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
4 terms
|
 |
|
Biological process
|
cellular response to drug
|
1 term
|
 |
|
Biochemical function
|
binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
39:14779-14786
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells.
|
|
K.Natarajan,
M.W.Sawicki,
D.H.Margulies,
R.A.Mariuzza.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
CD69 is a widely expressed type II transmembrane glycoprotein related to the
C-type animal lectins that exhibits regulated expression on a variety of cells
of the hematopoietic lineage, including neutrophils, monocytes, T cells, B
cells, natural killer (NK) cells, and platelets. Activation of T lymphocytes
results in the induced expression of CD69 at the cell surface. In addition,
cross-linking of CD69 by specific antibodies leads to the activation of cells
bearing this receptor and to the induction of effector functions. However, the
physiological ligand of CD69 is unknown. We report here the X-ray crystal
structure of the extracellular C-type lectin-like domain (CTLD) of human CD69 at
2.27 A resolution. Recombinant CD69 was expressed in bacterial inclusion bodies
and folded in vitro. The protein, which exists as a disulfide-linked homodimer
on the cell surface, crystallizes as a symmetrical dimer, similar to those
formed by the related NK cell receptors Ly49A and CD94. The structure reveals
conservation of the C-type lectin-like fold, including preservation of the two
alpha-helical regions found in Ly49A and mannose-binding protein (MBP). However,
only one of the nine residues coordinated to Ca(2+) in MBP is conserved in CD69
and no bound Ca(2+) is evident in the crystal structure. Surprisingly, electron
density suggestive of a puckered six-membered ring was discovered at a site
structurally analogous to the ligand-binding sites of MBP and Ly49A. This
sugar-like density may represent, or mimic, part of the natural ligand
recognized by CD69.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Lopes-Ferreira,
G.S.Magalhães,
J.H.Fernandez,
I.d.e. .L.Junqueira-de-Azevedo,
P.Le Ho,
C.Lima,
R.H.Valente,
and
A.M.Moura-da-Silva
(2011).
Structural and biological characterization of Nattectin, a new C-type lectin from the venomous fish Thalassophryne nattereri.
|
| |
Biochimie, 93,
971-980.
|
 |
|
|
|
|
 |
M.M.Bauer,
and
K.M.Reed
(2011).
Extended sequence of the turkey MHC B-locus and sequence variation in the highly polymorphic B-G loci.
|
| |
Immunogenetics, 63,
209-221.
|
 |
|
|
|
|
 |
A.J.Bankovich,
L.R.Shiow,
and
J.G.Cyster
(2010).
CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4.
|
| |
J Biol Chem, 285,
22328-22337.
|
 |
|
|
|
|
 |
A.Yokohama,
A.Mishra,
T.Mitsui,
B.Becknell,
J.Johns,
D.Curphey,
B.W.Blaser,
J.B.Vandeusen,
H.Mao,
J.Yu,
and
M.A.Caligiuri
(2010).
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.
|
| |
Leuk Res, 34,
203-209.
|
 |
|
|
|
|
 |
H.Huang,
X.Zheng,
Z.Tian,
and
R.Sun
(2010).
Peptide mimicry of AICL inhibits cytolysis of NK cells by blocking NKp80-AICL recognition.
|
| |
Immunol Invest, 39,
587-597.
|
 |
|
|
|
|
 |
P.Pompach,
P.Man,
D.Kavan,
K.Hofbauerová,
V.Kumar,
K.Bezouska,
V.Havlícek,
and
P.Novák
(2009).
Modified electrophoretic and digestion conditions allow a simplified mass spectrometric evaluation of disulfide bonds.
|
| |
J Mass Spectrom, 44,
1571-1578.
|
 |
|
|
|
|
 |
A.Prado-Drayer,
J.Teppa,
P.Sánchez,
and
M.I.Camejo
(2008).
Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
|
| |
Am J Reprod Immunol, 60,
66-74.
|
 |
|
|
|
|
 |
S.L.Rogers,
and
J.Kaufman
(2008).
High allelic polymorphism, moderate sequence diversity and diversifying selection for B-NK but not B-lec, the pair of lectin-like receptor genes in the chicken MHC.
|
| |
Immunogenetics, 60,
461-475.
|
 |
|
|
|
|
 |
A.A.Watson,
J.Brown,
K.Harlos,
J.A.Eble,
T.S.Walter,
and
C.A.O'Callaghan
(2007).
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2.
|
| |
J Biol Chem, 282,
3165-3172.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Spreu,
E.C.Kienle,
B.Schrage,
and
A.Steinle
(2007).
CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family.
|
| |
Immunogenetics, 59,
903-912.
|
 |
|
|
|
|
 |
L.C.Sullivan,
C.S.Clements,
T.Beddoe,
D.Johnson,
H.L.Hoare,
J.Lin,
T.Huyton,
E.J.Hopkins,
H.H.Reid,
M.C.Wilce,
J.Kabat,
F.Borrego,
J.E.Coligan,
J.Rossjohn,
and
A.G.Brooks
(2007).
The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.
|
| |
Immunity, 27,
900-911.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Ping,
T.M.Vondriska,
C.J.Creighton,
T.K.Gandhi,
Z.Yang,
R.Menon,
M.S.Kwon,
S.Y.Cho,
G.Drwal,
M.Kellmann,
S.Peri,
S.Suresh,
M.Gronborg,
H.Molina,
R.Chaerkady,
B.Rekha,
A.S.Shet,
R.E.Gerszten,
H.Wu,
M.Raftery,
V.Wasinger,
P.Schulz-Knappe,
S.M.Hanash,
Y.K.Paik,
W.S.Hancock,
D.J.States,
G.S.Omenn,
and
A.Pandey
(2005).
A functional annotation of subproteomes in human plasma.
|
| |
Proteomics, 5,
3506-3519.
|
 |
|
|
|
|
 |
R.Biassoni,
and
N.Dimasi
(2005).
Human natural killer cell receptor functions and their implication in diseases.
|
| |
Expert Rev Clin Immunol, 1,
405-417.
|
 |
|
|
|
|
 |
T.Ishigaki,
I.Ohki,
T.Oyama,
S.Machida,
K.Morikawa,
and
S.Tate
(2005).
Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 61,
524-527.
|
 |
|
|
|
|
 |
S.Radaev,
and
P.D.Sun
(2003).
Structure and function of natural killer cell surface receptors.
|
| |
Annu Rev Biophys Biomol Struct, 32,
93.
|
 |
|
|
|
|
 |
K.Natarajan,
N.Dimasi,
J.Wang,
R.A.Mariuzza,
and
D.H.Margulies
(2002).
Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination.
|
| |
Annu Rev Immunol, 20,
853-885.
|
 |
|
|
|
|
 |
M.M.Mullen,
K.M.Haan,
R.Longnecker,
and
T.S.Jardetzky
(2002).
Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1.
|
| |
Mol Cell, 9,
375-385.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Kogelberg,
and
T.Feizi
(2001).
New structural insights into lectin-type proteins of the immune system.
|
| |
Curr Opin Struct Biol, 11,
635-643.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2001).
Survey of the year 2000 commercial optical biosensor literature.
|
| |
J Mol Recognit, 14,
273-294.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|